41 – 50 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Bexarotene prodrugs: Targeting through cleavage by NQO1 (DT-diaphorase).
(
- Contribution to journal › Article
-
Mark
Impact of estrogen receptor beta activation on functional recovery after experimental stroke.
(
- Contribution to journal › Article
-
Mark
Apicidin Sensitizes Pancreatic Cancer Cells to Gemcitabine by Epigenetically Regulating MUC4 Expression.
(
- Contribution to journal › Article
- 2013
-
Mark
Nonsteroidal Selective Androgen Receptor Modulators and Selective Estrogen Receptor β Agonists Moderate Cognitive Deficits and Amyloid-β Levels in a Mouse Model of Alzheimer's Disease.
(
- Contribution to journal › Article
-
Mark
Low Dose Bexarotene Treatment Rescues Dopamine Neurons and Restores Behavioral Function in Models of Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Design of a Highly Selective and Potent Class of Non-planar Estrogen Receptor Agonists
(
- Contribution to journal › Article
-
Mark
The A-CD analogue of 16 beta,17 alpha-estriol is a potent and highly selective estrogen receptor beta agonist
(
- Contribution to journal › Article
-
Mark
A Robust Screening Assay For Diamond Blackfan Anemia Candidate Drugs
(
- Contribution to journal › Published meeting abstract
-
Mark
AC-186, a Selective Nonsteroidal Estrogen Receptor beta Agonist, Shows Gender Specific Neuroprotection in a Parkinson's Disease Rat Model
(
- Contribution to journal › Article
- 2012
-
Mark
Enantioselective Synthesis of Substituted Piperidines by Addition of Aryl Grignard Reagents to Pyridine N-Oxides.
2012) In Organic Letters(
- Contribution to journal › Article